Martin Goros

620 total citations
9 papers, 456 citations indexed

About

Martin Goros is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Martin Goros has authored 9 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Martin Goros's work include Acute Myeloid Leukemia Research (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Cancer-related Molecular Pathways (2 papers). Martin Goros is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Cancer-related Molecular Pathways (2 papers). Martin Goros collaborates with scholars based in United States, Greece and Denmark. Martin Goros's co-authors include Jonathan Gelfond, Zhihui Chang, Kenneth Cusi, Christopher Louden, Joan Hecht, Romina Lomonaco, Beverly Orsak, Ariel E. Feldstein, Amy Webb and Fermin O. Tio and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Hepatology.

In The Last Decade

Martin Goros

9 papers receiving 445 citations

Peers

Martin Goros
Roman Liebe Germany
Martin Goros
Citations per year, relative to Martin Goros Martin Goros (= 1×) peers Roman Liebe

Countries citing papers authored by Martin Goros

Since Specialization
Citations

This map shows the geographic impact of Martin Goros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Goros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Goros more than expected).

Fields of papers citing papers by Martin Goros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Goros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Goros. The network helps show where Martin Goros may publish in the future.

Co-authorship network of co-authors of Martin Goros

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Goros. A scholar is included among the top collaborators of Martin Goros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Goros. Martin Goros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Scherber, Robyn M., Martin Goros, Jonathan Gelfond, et al.. (2020). Body Mass Index and Total Symptom Burden in Myeloproliferative Neoplasms Discovery of a U-shaped Association. Cancers. 12(8). 2202–2202. 15 indexed citations
2.
Desai, Parth, et al.. (2019). Pretreatment obesity prolongs survival in elderly patients (≥65 years) with head and neck cancer (HNC).. Journal of Clinical Oncology. 37(15_suppl). 6052–6052. 1 indexed citations
3.
Liss, Michael A., James R. White, Martin Goros, et al.. (2018). Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer. European Urology. 74(5). 575–582. 137 indexed citations
4.
Gelfond, Jonathan, Martin Goros, Brian Hernandez, & Alex Bokov. (2018). A System for an Accountable Data Analysis Process in R. The R Journal. 10(1). 6–6. 16 indexed citations
5.
Arora, Sukeshi Patel, Vincent Hurez, Steffan T. Nawrocki, et al.. (2016). Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer. Oncotarget. 7(37). 59087–59097. 69 indexed citations
6.
Ha, Chul S., Joel Michalek, Richard Elledge, et al.. (2015). p53‐Based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study. Molecular Oncology. 10(1). 148–156. 9 indexed citations
7.
Ha, Chul S., Joel Michalek, Richard Elledge, et al.. (2014). P53 Based Strategy to Reduce Hematological Toxicity of Chemotherapy: Emerging Support from a Phase II Trial. Blood. 124(21). 4809–4809. 1 indexed citations
8.
Rowe, Julie, Sukeshi Patel Arora, Alberto Parra, et al.. (2013). An evaluation of elderly patients (≥70years old) enrolled in Phase I clinical trials at University of Texas Health Science Center at San Antonio-Cancer Therapy Research Center from 2009 to 2011. Journal of Geriatric Oncology. 5(1). 65–70. 15 indexed citations
9.
Cusi, Kenneth, Zhihui Chang, Romina Lomonaco, et al.. (2013). Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. Journal of Hepatology. 60(1). 167–174. 193 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026